End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
4.21
CNY
|
+1.20%
|
|
+6.31%
|
+12.57%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
22,108
|
26,411
|
41,768
|
44,131
|
33,668
|
31,558
|
Enterprise Value (EV)
1 |
25,986
|
33,286
|
39,338
|
42,049
|
29,330
|
32,018
|
P/E ratio
|
9.68
x
|
10.6
x
|
8.68
x
|
9.73
x
|
8.1
x
|
11.6
x
|
Yield
|
6.11%
|
11.2%
|
6.06%
|
3.1%
|
4.51%
|
8.56%
|
Capitalization / Revenue
|
2.61
x
|
2.69
x
|
2.82
x
|
2.29
x
|
1.57
x
|
1.65
x
|
EV / Revenue
|
3.07
x
|
3.39
x
|
2.66
x
|
2.18
x
|
1.37
x
|
1.67
x
|
EV / EBITDA
|
7.73
x
|
9.67
x
|
9
x
|
6.63
x
|
5.39
x
|
8.09
x
|
EV / FCF
|
8.64
x
|
20.1
x
|
6.62
x
|
11.6
x
|
9.71
x
|
15
x
|
FCF Yield
|
11.6%
|
4.98%
|
15.1%
|
8.61%
|
10.3%
|
6.66%
|
Price to Book
|
1.35
x
|
1.4
x
|
2.01
x
|
1.95
x
|
1.31
x
|
1.17
x
|
Nbr of stocks (in thousands)
|
8,438,017
|
8,438,017
|
8,438,017
|
8,438,017
|
8,438,017
|
8,438,017
|
Reference price
2 |
2.620
|
3.130
|
4.950
|
5.230
|
3.990
|
3.740
|
Announcement Date
|
4/18/19
|
4/21/20
|
4/26/21
|
4/19/22
|
4/27/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
8,473
|
9,805
|
14,804
|
19,297
|
21,460
|
19,124
|
EBITDA
1 |
3,362
|
3,444
|
4,371
|
6,344
|
5,441
|
3,960
|
EBIT
1 |
2,428
|
2,418
|
3,027
|
5,069
|
3,847
|
2,460
|
Operating Margin
|
28.66%
|
24.66%
|
20.45%
|
26.27%
|
17.93%
|
12.86%
|
Earnings before Tax (EBT)
1 |
2,606
|
2,806
|
5,868
|
5,418
|
4,950
|
3,099
|
Net income
1 |
2,285
|
2,492
|
4,815
|
4,536
|
4,157
|
2,723
|
Net margin
|
26.97%
|
25.41%
|
32.53%
|
23.51%
|
19.37%
|
14.24%
|
EPS
2 |
0.2708
|
0.2953
|
0.5706
|
0.5376
|
0.4927
|
0.3227
|
Free Cash Flow
1 |
3,008
|
1,657
|
5,941
|
3,622
|
3,021
|
2,132
|
FCF margin
|
35.5%
|
16.9%
|
40.13%
|
18.77%
|
14.08%
|
11.15%
|
FCF Conversion (EBITDA)
|
89.46%
|
48.13%
|
135.9%
|
57.08%
|
55.53%
|
53.84%
|
FCF Conversion (Net income)
|
131.64%
|
66.51%
|
123.38%
|
79.84%
|
72.67%
|
78.3%
|
Dividend per Share
2 |
0.1600
|
0.3500
|
0.3000
|
0.1620
|
0.1800
|
0.3200
|
Announcement Date
|
4/18/19
|
4/21/20
|
4/26/21
|
4/19/22
|
4/27/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,879
|
6,875
|
-
|
-
|
-
|
460
|
Net Cash position
1 |
-
|
-
|
2,430
|
2,082
|
4,337
|
-
|
Leverage (Debt/EBITDA)
|
1.154
x
|
1.996
x
|
-
|
-
|
-
|
0.1161
x
|
Free Cash Flow
1 |
3,008
|
1,657
|
5,941
|
3,622
|
3,021
|
2,132
|
ROE (net income / shareholders' equity)
|
14%
|
13.7%
|
23.5%
|
20.7%
|
17.2%
|
10.4%
|
ROA (Net income/ Total Assets)
|
6.47%
|
5.39%
|
5.8%
|
9.08%
|
6.42%
|
3.89%
|
Assets
1 |
35,328
|
46,257
|
83,000
|
49,947
|
64,787
|
69,997
|
Book Value Per Share
2 |
1.940
|
2.240
|
2.460
|
2.690
|
3.050
|
3.190
|
Cash Flow per Share
2 |
0.0900
|
0.1300
|
0.5200
|
0.2600
|
0.5700
|
0.4900
|
Capex
1 |
71.4
|
249
|
380
|
608
|
951
|
2,165
|
Capex / Sales
|
0.84%
|
2.54%
|
2.57%
|
3.15%
|
4.43%
|
11.32%
|
Announcement Date
|
4/18/19
|
4/21/20
|
4/26/21
|
4/19/22
|
4/27/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| +12.57% | 4.91B | | +2.80% | 103B | | +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +3.89% | 32.41B | | +6.82% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|